Recurrence time in chronic posttraumatic osteomyelitis of the tibia
https://doi.org/10.52420/2071-5943-2022-21-2-78-80
Abstract
Chronic posttraumatic osteomyelitis is a difficult-to-cure disease of the musculoskeletal system. The relationship between the course of the disease and the presence of type 2 diabetes mellitus has been revealed. It is necessary to predict the time of remission after initial diagnosis in this concomitant pathology. The paper includes data on the rehabilitation outcome of 57 patients with Ciery-Mader 3A (group 1) and 3B (group 2) osteomyelitis. Type 2 diabetes mellitus was a factor of systemic deficiency in wound healing in group 2. Clinical, radiological, and descriptive statistics methods were used. In patients with chronic osteomyelitis and concomitant type 2 diabetes mellitus, the risk of recurrence of purulent inflammatory process in the first year of follow-up increased by 20%. In the absence of systemic compromising factors, purulent process recurrence became more likely in the long-term follow-up periods up to 5 years.
About the Authors
V. A. Vohmjanin
Ural State Medical University
Russian Federation
Russian Federation
Valerij A. Vohmjanin – Resident.
Ekaterinburg.
R. T. Gil'manov
Central City Clinical Hospital № 23
Russian Federation
Russian Federation
Rinat T. Gil'manov - Head of the Department of Purulent Surgery.
Ekaterinburg.
D. Yu. Borzunov
Ural State Medical University; Central City Clinical Hospital № 23
Russian Federation
Russian Federation
Dmitry Yu. Borzunov - Doctor of Medicine, Associate Professor.
Ekaterinburg.
References
1. Ишутов И., Алексеев Д. Основные принципы озонотерапии в лечении пациентов с хроническим остеомиелитом // Вестник экспериментальной и клинической хирургии. – 2011. – Т. 4, № 2. – С. 314-320.
2. Calhoun J. H., Manring M. M., Shirtliff M. Osteomyelitis of the long bones // Semin. Plast. Surg. – 2009, vol. 23, no. 2. – P. 59-72. – DOI: 10.1055/s0029-1214158.
3. Brause, B. Infections with prostheses in bones and joints. In: Mandell G.L., Bennett J.E., Dolin R., eds. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 7th Ed. Philadelphia, Churchill Livingstone, Elsevier, 2010, vol. 1, part II, section K, pp. 1469.
4. Pathogen identification in 84 Patients with post-traumatic osteomyelitis after limb fractures / Yang L., Feng J., Liu J. [et al.] // Ann Palliat Med. – 2020 Mar;9(2):451-458. doi: 10.21037/apm.2020.03.29.
5. Hatzenbuehler, J. Diagnosis and management of osteomyelitis / Hatzenbuehler J., Pulling T. J. // Am Fam Physician. – 2011 Nov 1;84(9):1027-33.
6. Cierny G., Mader J. T., Penninck J. J. A clinical staging system for adult osteomyelitis // Contemp Orthop. – 1985; 10:17-37.
7. Trends in the epidemiology of osteomyelitis: a population-based study, 1969 to 2009 / Kremers H. M., Nwojo M. E., Ransom J. E. [et al.] // J 3rd, Huddleston PM 3rd. J Bone Joint Surg Am. –2015 May 20;97(10):837-45. – doi: 10.2106/JBJS.N.01350.
8. Long-term follow-up trial of oral rifampin-cotrimoxazole combination versus intravenous cloxacillin in treatment of chronic staphylococcal osteomyelitis / Euba G., Murillo O., Fernández-Sabé N. [et al.] // Antimicrob Agents Chemother. – 2009;53:2672–2676.
9. Management of chronic osteomyelitis of the femur and tibia: a scoping review. Arshad Z., Lau E. J., Aslam A., Thahir A. // Krkovic M.EFORT Open Rev. 2021 Sep 14;6(9):704-715. doi: 10.1302/2058-5241.6.200136.
Review
For citations:
Vohmjanin VA, Gil'manov RT, Borzunov DY. Recurrence time in chronic posttraumatic osteomyelitis of the tibia. Ural Medical Journal. 2022;21(2):78-80. (In Russ.) https://doi.org/10.52420/2071-5943-2022-21-2-78-80
Views:
248
Email this article 